Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron

Bell, G. C.; Caudle, K. E.; Whirl-Carrillo, M.; Gordon, R. J.; Hikino, K.; Prows, C. A.; Gaedigk, A.; Agundez, J. A. G.; Sadhasivam, S.; Klein, T. E.; Schwab, M.

dc.contributor.author	Schwab, Matthias
dc.date.accessioned	2017-11-27T12:51:17Z
dc.date.available	2017-11-27T12:51:17Z
dc.date.issued	2017
dc.identifier.issn	1532-6535
dc.identifier.uri	http://hdl.handle.net/10900/78732
dc.language.iso	en	de_DE
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1002/cpt.598	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_00101
utue.publikation.seiten	213-218	de_DE
utue.personen.roh	Bell, G. C.
utue.personen.roh	Caudle, K. E.
utue.personen.roh	Whirl-Carrillo, M.
utue.personen.roh	Gordon, R. J.
utue.personen.roh	Hikino, K.
utue.personen.roh	Prows, C. A.
utue.personen.roh	Gaedigk, A.
utue.personen.roh	Agundez, J. A. G.
utue.personen.roh	Sadhasivam, S.
utue.personen.roh	Klein, T. E.
utue.personen.roh	Schwab, M.
dcterms.isPartOf.ZSTitelID	Clinical Pharmacology & Therapeutics	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	102	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE